Dan Groman Enfusion, Inc. (ENFN) insider trading activity

Dan Groman is Chief Technology Officer of Enfusion, Inc.. Currently has a direct ownership of 133,828 shares of ENFN, which is worth approximately $1.35 Million. The most recent transaction as insider was on Nov 14, 2023, when has been sold 5,000 shares (Class A Common Stock) at a price of $9.97 per share, resulting in proceeds of $49,850. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 134K

0% 3M change

0% 12M change

Total Value Held $1.35 Million

Dan Groman Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 14 2023	SELL Open market or private sale	$49,850 $9.97 p/Share	5,000 Reduced 3.6%	133,828 Class A Common Stock
Oct 17 2023	SELL Open market or private sale	$45,450 $9.09 p/Share	5,000 Reduced 3.48%	138,828 Class A Common Stock
Sep 19 2023	SELL Open market or private sale	$45,350 $9.07 p/Share	5,000 Reduced 3.36%	143,828 Class A Common Stock
Aug 17 2023	SELL Payment of exercise price or tax liability	$65,971 $8.18 p/Share	8,065 Reduced 5.14%	148,828 Class A Common Stock
Aug 17 2023	BUY Grant, award, or other acquisition	-	19,223 Added 10.91%	156,893 Class A Common Stock
Aug 16 2023	SELL Payment of exercise price or tax liability	$104,744 $7.94 p/Share	13,192 Reduced 8.74%	137,670 Class A Common Stock
Aug 16 2023	BUY Grant, award, or other acquisition	-	31,444 Added 17.25%	150,862 Class A Common Stock
Aug 14 2023	SELL Open market or private sale	$13,886 $7.89 p/Share	1,760 Reduced 1.45%	119,418 Class A Common Stock
Aug 11 2023	SELL Open market or private sale	$14,985 $8.1 p/Share	1,850 Reduced 1.55%	117,133 Class A Common Stock
Aug 11 2023	BUY Grant, award, or other acquisition	-	4,045 Added 3.23%	121,178 Class A Common Stock
Aug 10 2023	SELL Open market or private sale	$17,016 $8.08 p/Share	2,106 Reduced 1.81%	114,532 Class A Common Stock
Aug 10 2023	BUY Grant, award, or other acquisition	-	4,451 Added 3.61%	118,983 Class A Common Stock
Aug 09 2023	SELL Open market or private sale	$19,277 $8.32 p/Share	2,317 Reduced 2.03%	111,783 Class A Common Stock
Aug 09 2023	BUY Grant, award, or other acquisition	-	4,855 Added 4.0%	116,638 Class A Common Stock
Aug 08 2023	BUY Grant, award, or other acquisition	-	5,259 Added 4.41%	114,100 Class A Common Stock
Jul 17 2023	SELL Open market or private sale	$43,848 $11.31 p/Share	3,877 Reduced 3.44%	108,841 Class A Common Stock
Jun 20 2023	SELL Open market or private sale	$34,350 $8.86 p/Share	3,877 Reduced 3.33%	112,718 Class A Common Stock
Jun 15 2023	SELL Payment of exercise price or tax liability	$173,009 $8.87 p/Share	19,505 Reduced 14.33%	116,595 Class A Common Stock
Jun 15 2023	BUY Grant, award, or other acquisition	-	44,260 Added 24.54%	136,100 Class A Common Stock
May 24 2023	SELL Payment of exercise price or tax liability	$377,705 $7.93 p/Share	47,630 Reduced 34.15%	91,840 Class A Common Stock
May 24 2023	BUY Grant, award, or other acquisition	-	113,538 Added 44.88%	139,470 Class A Common Stock
May 22 2023	SELL Open market or private sale	$428,860 $7.96 p/Share	53,877 Reduced 67.51%	25,932 Class A Common Stock
May 10 2023	SELL Open market or private sale	$125,500 $8.34 p/Share	15,048 Reduced 15.86%	79,809 Class A Common Stock
Apr 25 2023	SELL Payment of exercise price or tax liability	$76,794 $8.33 p/Share	9,219 Reduced 8.86%	94,857 Class A Common Stock
Apr 25 2023	BUY Grant, award, or other acquisition	-	21,974 Added 17.43%	104,076 Class A Common Stock

Dan Groman

Chief Technology Officer

Chicago, IL

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ENFN shares.

Notify only if

Value

Insider Trading

Get notified when an Enfusion, Inc. insider buys or sells ENFN shares.

Notify only if

Operation

Value

Type

News

Receive news related to Enfusion, Inc.

Track Activities on ENFN

Account